{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:39:21Z","timestamp":1793691561639,"version":"4.5.1"},"reference-count":164,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Osteoarthritis (OA) is a highly heterogeneous whole-joint disease. Current treatment strategies, which primarily focus on symptomatic pain relief, are insufficient to address the therapeutic needs of patients with distinct clinical phenotypes. Accumulating evidence has demonstrated that the empirical use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) has shown limited efficacy in OA cohorts selected on the basis of inflammatory features, underscoring the need to more precisely define inflammation-driven OA and elucidate its underlying pathogenic mechanisms. Persistent local inflammation is increasingly recognized as a prominent feature of inflammation-driven OA. Rather than being merely secondary to mechanical injury or degenerative changes, this inflammatory state is associated with sustained release of damage-associated molecular patterns (DAMPs), aberrant activation of innate immunity, and amplification of inflammatory signaling. However, no consensus criteria have been established to define inflammation-driven OA. The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome integrates diverse danger signals, including extracellular ATP, crystal deposition, ionic fluxes and mitochondrial oxidative stress. Its activation promotes caspase-1 activation, the maturation and release of inflammatory cytokines, and gasdermin D (GSDMD)-mediated pyroptosis. Through cell type-specific responses and intercellular crosstalk within the OA joint microenvironment, aberrant NLRP3 inflammasome activation may sustain local inflammatory amplification, contribute to OA progression, and exacerbate joint tissue damage. In this review, we discuss the basis for stratifying inflammation-driven OA and the challenges associated with its treatment, delineate the potential pathological role of the NLRP3 inflammasome, and explore its potential as both a candidate mechanism-based biomarker and a therapeutic target. We propose that NLRP3 inflammasome activation may provide a mechanistically informative dimension for OA stratification, thereby offering a conceptual framework for moving beyond conventional symptom-oriented management toward mechanism-informed precision intervention.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1938807","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:00:01Z","timestamp":1790258401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Focus on the NLRP3 inflammasome: its role in the pathogenesis and therapeutic potential of inflammation-driven osteoarthritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Fengyuan","family":"Li","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lanzhou University Second Hospital","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjie","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lanzhou University Second Hospital","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lanzhou University Second Hospital","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lanzhou University Second Hospital","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7326\/annals-24-01249","article-title":"Knee osteoarthritis","volume":"177","author":"Gelber","year":"2024","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225041","article-title":"Eular recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update","volume":"83","author":"Moseng","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020355","article-title":"Advances and challenges in the pursuit of disease-modifying osteoarthritis drugs: A review of 2010-2024 clinical trials","volume":"13","author":"Brandt","year":"2025","journal-title":"Biomedicines"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-026-06845-9","article-title":"Osteoarthritis phenotypes: Advancing precision medicine through clinical, structural, and molecular stratification","volume":"50","author":"Vaishya","year":"2026","journal-title":"Int Orthop"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221763","article-title":"Osteoarthritis endotype discovery via clustering of biochemical marker data","volume":"81","author":"Angelini","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14737159.2024.2315282","article-title":"From biochemical markers to molecular endotypes of osteoarthritis: A review on validated biomarkers","volume":"24","author":"Hannani","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2025.100572","article-title":"The inflammatory endotype in osteoarthritis: Reflections from the 2024 Oarsi Clinical Trials Symposium (Cts) with a special emphasis on feasibility for clinical development","volume":"7","author":"Karsdal","year":"2025","journal-title":"Osteoarthr Cartil Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2025.2550639","article-title":"Diagnosing, treating and monitoring the inflammatory endotype in osteoarthritis clinical trials","volume":"25","author":"Thudium","year":"2025","journal-title":"Expert Rev Mol Diagn"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158381","article-title":"Phenotype diversity of macrophages in osteoarthritis: Implications for development of macrophage modulating therapies","volume":"23","author":"Mushenkova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00749-9","article-title":"Synovial inflammation in osteoarthritis progression","volume":"18","author":"Sanchez-Lopez","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1273174","article-title":"Mechanistic and therapeutic insights into the function of Nlrp3 inflammasome in sterile arthritis","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/biology14010071","article-title":"Nlrp3 inflammasome-mediated osteoarthritis: The role of epigenetics","volume":"14","author":"Liu","year":"2025","journal-title":"Biol (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00594-6","article-title":"Osteoarthritis","volume":"11","author":"Tang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2025.03.003","article-title":"Risk factors for the development of knee osteoarthritis across the lifespan: A systematic review and meta-analysis","volume":"33","author":"Duong","year":"2025","journal-title":"Osteoarthritis Cartilage"},{"key":"B16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41413-022-00226-9","article-title":"Current understanding of osteoarthritis pathogenesis and relevant new approaches","volume":"10","author":"Tong","year":"2022","journal-title":"Bone Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2024.02.888","article-title":"Timing is everything: Towards classification criteria for early-stage symptomatic knee osteoarthritis","volume":"32","author":"Mahmoudian","year":"2024","journal-title":"Osteoarthritis Cartilage"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4085\/1062-6050-0470.23","article-title":"Persistent early knee osteoarthritis symptoms from 6 to 12 months after anterior cruciate ligament reconstruction","volume":"59","author":"Harkey","year":"2024","journal-title":"J Athl Train"},{"key":"B19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s41927-025-00557-0","article-title":"Towards stratification in osteoarthritis: A review of the scientific terminology used in published basic research","volume":"9","author":"Pattappa","year":"2025","journal-title":"BMC Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ostima.2024.100257","article-title":"Deconstructing the \"types\" of osteoarthritis","volume":"5","author":"Hunter","year":"2025","journal-title":"Osteoarthr Imaging"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.03.009","article-title":"Molecular endotypes and theratypes in osteoarthritis: Transforming a concept into reality with deep learning and multiomics","volume":"84","author":"Binvignat","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01305-x","article-title":"Novel approaches to the stratified management of knee osteoarthritis","volume":"21","author":"Fuggle","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-025-01551-3","article-title":"Emerging concepts and challenges in the development of disease-modifying osteoarthritis drugs - a more refined perspective","volume":"48","author":"Jenei-Lanzl","year":"2025","journal-title":"Arch Pharm Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-022-04191-6","article-title":"Structural phenotypes of knee osteoarthritis: Potential clinical and research relevance","volume":"52","author":"Roemer","year":"2023","journal-title":"Skeletal Radiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.21037\/atm-20-4673","article-title":"Development and formulation of the classification criteria for osteoarthritis","volume":"8","author":"Huang","year":"2020","journal-title":"Ann Transl Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-026-03742-9","article-title":"Cytokine profiling of molecular endotypes of knee osteoarthritis: Insights from the Imi-Approach cohort","volume":"28","author":"Hannani","year":"2026","journal-title":"Arthritis Res Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000567","article-title":"Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: Biochemical markers associated with emerging clinical phenotypes and molecular endotypes","volume":"31","author":"Mobasheri","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12891-016-1286-2","article-title":"Identification of clinical phenotypes in knee osteoarthritis: A systematic review of the literature","volume":"17","author":"Dell'Isola","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2017.02.804","article-title":"Knee effusion-synovitis volume measurement and effects of vitamin D supplementation in patients with knee osteoarthritis","volume":"25","author":"Wang","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07042-y","article-title":"Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials","volume":"43","author":"Zhu","year":"2024","journal-title":"Clin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13075-026-03819-5","article-title":"Revisiting osteoarthritis as an inflammatory disease: Characterization of synovitis grading and synovial pathotypes in surgical specimens","volume":"28","author":"Ciaffi","year":"2026","journal-title":"Arthritis Res Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/ard.47.4.300","article-title":"The synovial membrane in osteoarthritis: A histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies","volume":"47","author":"Revell","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.1359","article-title":"Low-dose methotrexate for the treatment of inflammatory knee osteoarthritis: A randomized clinical trial","volume":"185","author":"Zhu","year":"2025","journal-title":"JAMA Intern Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S520465","article-title":"Is it time to revisit the role of interleukin-1 inhibitors in osteoarthritis","volume":"18","author":"Brom","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13018-023-03590-2","article-title":"Efficacy and safety of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Yu","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7326\/m20-0527","article-title":"Effects of interleukin-1\u03b2 inhibition on incident hip and knee replacement : Exploratory analyses from a randomized, double-blind, placebo-controlled trial","volume":"173","author":"Schieker","year":"2020","journal-title":"Ann Intern Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1038\/s41467-022-31519-6","article-title":"Single cell sequencing identifies clonally expanded synovial Cd4(+) T(Ph) cells expressing Gpr56 in rheumatoid arthritis","volume":"13","author":"Argyriou","year":"2022","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2021.12.007","article-title":"Single cell transcriptomics in human osteoarthritis synovium and in silico deconvoluted bulk rna sequencing","volume":"30","author":"Huang","year":"2022","journal-title":"Osteoarthritis Cartilage"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1042\/bst20190803","article-title":"How does methotrexate work","volume":"48","author":"Alqarni","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"Eular recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1164137","article-title":"Effects of synovial macrophages in osteoarthritis","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2020.01.007","article-title":"Macrophages regulate the progression of osteoarthritis","volume":"28","author":"Zhang","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1078414","article-title":"Comprehensive bulk and single-cell transcriptome profiling give useful insights into the characteristics of osteoarthritis associated synovial macrophages","volume":"13","author":"Liao","year":"2022","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.93283","article-title":"Synovial macrophage diversity and activation of M-Csf signaling in post-traumatic osteoarthritis","volume":"12","author":"Knights","year":"2025","journal-title":"Elife"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512143","article-title":"The role of alarmins in osteoarthritis pathogenesis: Hmgb1, S100b and Il-33","volume":"24","author":"Palumbo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0816","article-title":"The immunological facets of chondrocytes in osteoarthritis: A narrative review","volume":"51","author":"Sengprasert","year":"2023","journal-title":"J Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207993120","article-title":"Nos inhibition reverses Tlr2-induced chondrocyte dysfunction and attenuates age-related osteoarthritis","volume":"120","author":"Shen","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The Nlrp3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01275-w","article-title":"Nlrp3 inflammasome in neuroinflammation and central nervous system diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105365","article-title":"Activation and function of Nlrp3 inflammasome in bone and joint-related diseases","volume":"23","author":"Murakami","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature15514","article-title":"Cleavage of Gsdmd by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrrheum.2014.162","article-title":"Emerging regulators of the inflammatory process in osteoarthritis","volume":"11","author":"Liu-Bryan","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01629-2","article-title":"Targeting the Nlrp3 inflammasome as a novel therapeutic target for osteoarthritis","volume":"33","author":"Karmakar","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200940185","article-title":"Critical functions of priming and lysosomal damage for Nlrp3 activation","volume":"40","author":"Hornung","year":"2010","journal-title":"Eur J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3706421","article-title":"Betulinic acid attenuates osteoarthritis via limiting Nlrp3 inflammasome activation to decrease interleukin-1\u03b2 maturation and secretion","volume":"2023","author":"Liu","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/life12050731","article-title":"The role of inflammasomes in osteoarthritis and secondary joint degeneration diseases","volume":"12","author":"Ro\u0161kar","year":"2022","journal-title":"Life (Basel)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of Nlrp3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10564","DOI":"10.1038\/s41467-025-65578-2","article-title":"Atomic mechanisms of full-length Asc-mediated inflammasome assembly","volume":"16","author":"Xue","year":"2025","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41392-021-00650-z","article-title":"Inflammasomes as therapeutic targets in human diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03478-3","article-title":"Gasdermin D pore structure reveals preferential release of mature interleukin-1","volume":"593","author":"Xia","year":"2021","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101781","article-title":"Pyroptosis-induced inflammation and tissue damage","volume":"69","author":"Vasudevan","year":"2023","journal-title":"Semin Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01284-9","article-title":"Updated insights into the molecular networks for Nlrp3 inflammasome activation","volume":"22","author":"Paik","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/08830185.2024.2415688","article-title":"The Nlrp3 inflammasome: Mechanisms of activation, regulation, and role in diseases","volume":"44","author":"Dadkhah","year":"2025","journal-title":"Int Rev Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of Nlrp3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-021-01439-6","article-title":"The signaling pathways regulating Nlrp3 inflammasome activation","volume":"44","author":"Chen","year":"2021","journal-title":"Inflammation"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302839","article-title":"Fadd and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes","volume":"192","author":"Gurung","year":"2014","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3892\/ijmm.2025.5489","article-title":"Nlrp3 inflammasome in health and disease (review)","volume":"55","author":"Wang","year":"2025","journal-title":"Int J Mol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The Nlrp3 inflammasome: Activation and regulation","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00922-w","article-title":"How location and cellular signaling combine to activate the Nlrp3 inflammasome","volume":"19","author":"Akbal","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00421.2021","article-title":"The role of Cl(-) and K(+) efflux in Nlrp3 inflammasome and innate immune response activation","volume":"322","author":"Koumangoye","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41467-017-00227-x","article-title":"Clics-dependent chloride efflux is an essential and proximal upstream event for Nlrp3 inflammasome activation","volume":"8","author":"Tang","year":"2017","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-031023-125300","article-title":"Molecular activation of Nlrp3 inflammasome by particles and crystals: A continuing challenge of immunology and toxicology","volume":"64","author":"Ma","year":"2024","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.011751","article-title":"The zebrafish Nlrp3 inflammasome has functional roles in Asc-dependent interleukin-1\u03b2 maturation and gasdermin E-mediated pyroptosis","volume":"295","author":"Li","year":"2020","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3VMA1215-579RR","article-title":"Oxidized phosphatidylcholine induces the activation of Nlrp3 inflammasome in macrophages","volume":"101","author":"Yeon","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","article-title":"Oxidized DNA fragments exit mitochondria via Mptp- and Vdac-dependent channels to activate Nlrp3 inflammasome and interferon signaling","volume":"55","author":"Xian","year":"2022","journal-title":"Immunity"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab010","article-title":"Nlrp3 inflammasome as a key driver of vascular disease","volume":"118","author":"Takahashi","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167245","article-title":"Mechanisms and consequences of noncanonical inflammasome-mediated pyroptosis","volume":"434","author":"Wright","year":"2022","journal-title":"J Mol Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-025-01142-9","article-title":"New insights into the noncanonical inflammasome point to caspase-4 as a druggable target","volume":"25","author":"Elkayam","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000373","article-title":"Function and regulation of noncanonical caspase-4\/5\/11 inflammasome","volume":"204","author":"Matikainen","year":"2020","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000516064","article-title":"Caspase-11 noncanonical inflammasome: A novel key player in murine models of neuroinflammation and multiple sclerosis","volume":"28","author":"Yi","year":"2021","journal-title":"Neuroimmunomodulation"},{"key":"B85","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2147\/jir.S445573","article-title":"Pyroptosis in osteoarthritis: Molecular mechanisms and therapeutic implications","volume":"17","author":"Chen","year":"2024","journal-title":"J Inflammation Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.158","article-title":"Does lipopolysaccharide-mediated inflammation have a role in Oa","volume":"12","author":"Huang","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2016.05.008","article-title":"Both systemic and local lipopolysaccharide (Lps) burden are associated with knee Oa severity and inflammation","volume":"24","author":"Huang","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"B88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11926-018-0721-9","article-title":"Calcium-containing crystals and osteoarthritis: An unhealthy alliance","volume":"20","author":"Conway","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1111101108","article-title":"Nlrp3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy","volume":"108","author":"Jin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B90","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3892\/mmr.2024.13224","article-title":"Dicoumarol attenuates Nlrp3 inflammasome activation to inhibit inflammation and fibrosis in knee osteoarthritis","volume":"29","author":"Ge","year":"2024","journal-title":"Mol Med Rep"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00506","article-title":"Purinergic system signaling in metainflammation-associated osteoarthritis","volume":"7","author":"Gratal","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12891-021-04092-0","article-title":"A comparative analysis of Nlrp3-related inflammatory mediators in synovial fluid in temporomandibular joint osteoarthritis and internal derangement","volume":"22","author":"Jia","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.13198","article-title":"Estradiol inhibits Nlrp3 inflammasome in fibroblast-like synoviocytes activated by lipopolysaccharide and adenosine triphosphate","volume":"21","author":"Shi","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2363460","article-title":"Exploring the involvement of Nlrp3 and Il-1\u03b2 in osteoarthritis of the hand: Results from a pilot study","volume":"2019","author":"Fioravanti","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B95","doi-asserted-by":"publisher","first-page":"994","DOI":"10.7150\/ijbs.39945","article-title":"DNA methylation is involved in the pathogenesis of osteoarthritis by regulating Ctbp expression and Ctbp-mediated signaling","volume":"16","author":"Sun","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107150","article-title":"Lncrna Snhg7 alleviates Il-1\u03b2-induced osteoarthritis by inhibiting Mir-214-5p-mediated Ppargc1b signaling pathways","volume":"90","author":"Xu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203466","article-title":"Nf-Kb inducible Mir-30b-5p aggravates joint pain and loss of articular cartilage via targeting Sirt1-Foxo3a-mediated Nlrp3 inflammasome","volume":"13","author":"Xu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S243512","article-title":"Loratadine alleviates advanced glycation end product-induced activation of Nlrp3 inflammasome in human chondrocytes","volume":"14","author":"Gao","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.617270","article-title":"Usp7 inhibition alleviates H(2)O(2)-induced injury in chondrocytes via inhibiting Nox4\/Nlrp3 pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Front Pharmacol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-019-00986-3","article-title":"Sinomenine attenuates cartilage degeneration by regulating Mir-223-3p\/Nlrp3 inflammasome signaling","volume":"42","author":"Dong","year":"2019","journal-title":"Inflammation"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4139048","article-title":"Mcc950, the Nlrp3 inhibitor, protects against cartilage degradation in a mouse model of osteoarthritis","volume":"2021","author":"Ni","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8868361","article-title":"P2x7 receptor induces pyroptotic inflammation and cartilage degradation in osteoarthritis via Nf-Kb\/Nlrp3 crosstalk","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jot.2022.11.002","article-title":"Linear ubiquitination of Lkb1 activates Ampk pathway to inhibit Nlrp3 inflammasome response and reduce chondrocyte pyroptosis in osteoarthritis","volume":"39","author":"Chen","year":"2023","journal-title":"J Orthop Translat"},{"key":"B104","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13075-019-2085-6","article-title":"Inhibition of Nrf2\/Ho-1 signaling leads to increased activation of the Nlrp3 inflammasome in osteoarthritis","volume":"21","author":"Chen","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5534614","article-title":"Agnuside alleviates synovitis and fibrosis in knee osteoarthritis through the inhibition of Hif-1\u03b1 and Nlrp3 inflammasome","volume":"2021","author":"Zhang","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6326517","article-title":"Increased Hif-1\u03b1 in knee osteoarthritis aggravate synovial fibrosis via fibroblast-like synoviocyte pyroptosis","volume":"2019","author":"Zhang","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03174.x","article-title":"Expression and function of the Nalp3 inflammasome in rheumatoid synovium","volume":"129","author":"Kolly","year":"2010","journal-title":"Immunology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13075-025-03573-0","article-title":"Chondrocyte lysates activate Nlrp3 inflammasome-induced pyroptosis in synovial fibroblasts to exacerbate knee synovitis by downregulating Caveolin-1","volume":"27","author":"Du","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B109","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/mmr.2020.11736","article-title":"Relationship between the pyroptosis of fibroblast-like synoviocytes and Hmgb1 secretion in knee osteoarthritis","volume":"23","author":"Xiao","year":"2021","journal-title":"Mol Med Rep"},{"key":"B110","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12967-023-04313-1","article-title":"Targeting macrophagic Pim-1 alleviates osteoarthritis by inhibiting Nlrp3 inflammasome activation via suppressing mitochondrial Ros\/Cl(-) efflux signaling pathway","volume":"21","author":"Zhang","year":"2023","journal-title":"J Transl Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111220","article-title":"Degrasyn alleviates osteoarthritis by blocking macrophagic pyroptosis via suppressing Nlrp3\/Gsdmd signaling pathway and protecting chondrocytes","volume":"120","author":"Xie","year":"2024","journal-title":"Cell Signal"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.05.033","article-title":"Gyy4137-induced P65 sulfhydration protects synovial macrophages against pyroptosis by improving mitochondrial function in osteoarthritis development","volume":"71","author":"Ma","year":"2025","journal-title":"J Adv Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.05.014","article-title":"Modulating synovial macrophage pyroptosis and mitophagy interactions to mitigate osteoarthritis progression using functionalized nanoparticles","volume":"181","author":"Qi","year":"2024","journal-title":"Acta Biomater"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.607764","article-title":"Subchondral bone remodeling: A therapeutic target for osteoarthritis","volume":"8","author":"Zhu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3724\/abbs.2024017","article-title":"Subchondral osteoclasts and osteoarthritis: New insights and potential therapeutic avenues","volume":"56","author":"Chen","year":"2024","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101852","article-title":"Biomarkers for osteoarthritis: Current status and future prospects","volume":"37","author":"Mobasheri","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acr.25205","article-title":"Diagnostic accuracy of ultrasound for assessment of synovial abnormalities among patients with knee pain: A meta-analysis","volume":"76","author":"Liu","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.joca.2023.10.005","article-title":"Osteoarthritis year in review 2023: Imaging","volume":"32","author":"Jarraya","year":"2024","journal-title":"Osteoarthritis Cartilage"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2021.12.003","article-title":"Association between knee inflammation and knee pain in patients with knee osteoarthritis: A systematic review","volume":"30","author":"Dainese","year":"2022","journal-title":"Osteoarthritis Cartilage"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28223","article-title":"Impact of sustained synovitis on knee joint structural degeneration: 4-year Mri data from the Osteoarthritis Initiative","volume":"57","author":"Ramezanpour","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2021.04.014","article-title":"(18)F]Naf Pet-Mri provides direct in-vivo evidence of the association between bone metabolic activity and adjacent synovitis in knee osteoarthritis: A cross-sectional study","volume":"29","author":"MacKay","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2023.08.005","article-title":"Osteoarthritis year in review 2023: Metabolite and protein biomarkers","volume":"31","author":"Liu","year":"2023","journal-title":"Osteoarthritis Cartilage"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2023.09.007","article-title":"Serum proteomic biomarkers diagnostic of knee osteoarthritis","volume":"32","author":"Kraus","year":"2024","journal-title":"Osteoarthritis Cartilage"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-023-04284-w","article-title":"Biomarkers in osteoarthritis: Current status and outlook - the Fnih Biomarkers Consortium Progress Oa Study","volume":"52","author":"Hunter","year":"2023","journal-title":"Skeletal Radiol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10215027","article-title":"Synovial fluid cytokines, chemokines and Mmp levels in osteoarthritis patients with knee pain display a profile similar to many rheumatoid arthritis patients","volume":"10","author":"Meehan","year":"2021","journal-title":"J Clin Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab657","article-title":"Comment on: Association of serum levels of inflammatory markers and adipokines with joint symptoms and structures in participants with knee osteoarthritis: Reply","volume":"60","author":"Zhu","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B127","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.joca.2016.10.024","article-title":"Cross-sectional and longitudinal associations between serum inflammatory cytokines and knee bone marrow lesions in patients with knee osteoarthritis","volume":"25","author":"Zhu","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1186\/s12891-022-06017-x","article-title":"Serum periostin level is not sufficient to serve as a clinically applicable biomarker of osteoarthritis","volume":"23","author":"Tan","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"B129","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.joca.2024.10.003","article-title":"Osteoarthritis year in review 2024: Molecular biomarkers of osteoarthritis","volume":"33","author":"Welhaven","year":"2025","journal-title":"Osteoarthritis Cartilage"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.767512","article-title":"The expression of inflammasomes Nlrp1 and Nlrp3, toll-like receptors, and vitamin D receptor in synovial fibroblasts from patients with different types of knee arthritis","volume":"12","author":"Sakalyte","year":"2021","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"82s","DOI":"10.1177\/1947603520942941","article-title":"Synovial fluid biomarkers in knee osteoarthritis: A systematic review and quantitative evaluation using Bipeds criteria","volume":"13","author":"Boffa","year":"2021","journal-title":"Cartilage"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309677","article-title":"Development of methodology to support molecular endotype discovery from synovial fluid of individuals with knee osteoarthritis: The Stepup Oa Consortium","volume":"19","author":"Deng","year":"2024","journal-title":"PloS One"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/326267","article-title":"Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis","volume":"2013","author":"Sun","year":"2013","journal-title":"BioMed Res Int"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1302\/2046-3758.72.Bjr-2017-0253","article-title":"Effects of a phosphocitrate analogue on osteophyte, subchondral bone advance, and bone marrow lesions in Hartley Guinea pigs","volume":"7","author":"Sun","year":"2018","journal-title":"Bone Joint Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2013.1748","article-title":"P2x4 promotes interleukin-1\u03b2 production in osteoarthritis via Nlrp1","volume":"9","author":"Fan","year":"2014","journal-title":"Mol Med Rep"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.628330","article-title":"The P2x7 receptor in osteoarthritis","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2016.2770","article-title":"Blocking of the P2x7 receptor inhibits the activation of the Mmp-13 and Nf-Kb pathways in the cartilage tissue of rats with osteoarthritis","volume":"38","author":"Hu","year":"2016","journal-title":"Int J Mol Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15905","article-title":"Activating Nrf2 signalling alleviates osteoarthritis development by inhibiting inflammasome activation","volume":"24","author":"Yan","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22951","article-title":"Effects of quercetin on apoptosis and extracellular matrix degradation of chondrocytes induced by oxidative stress-mediated pyroptosis","volume":"36","author":"Wang","year":"2022","journal-title":"J Biochem Mol Toxicol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-019-1307-6","article-title":"Icariin alleviates osteoarthritis by inhibiting Nlrp3-mediated pyroptosis","volume":"14","author":"Zu","year":"2019","journal-title":"J Orthop Surg Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167309","article-title":"Crystal structure of Nlrp3 Nacht domain with an inhibitor defines mechanism of inflammasome inhibition","volume":"433","author":"Dekker","year":"2021","journal-title":"J Mol Biol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the Nlrp3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13075-021-02668-8","article-title":"Gasdermin D deficiency attenuates arthritis induced by traumatic injury but not autoantibody-assembled immune complexes","volume":"23","author":"Yang","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B145","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13018-021-02262-3","article-title":"Co-treatment with disulfiram and glycyrrhizic acid suppresses the inflammatory response of chondrocytes","volume":"16","author":"Li","year":"2021","journal-title":"J Orthop Surg Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.12.004","article-title":"High-throughput screening identifies Fda approved drug mitiglinide as a novel pyroptosis inhibitor and therapeutic agent for osteoarthritis","volume":"87","author":"Zhang","year":"2025","journal-title":"J Adv Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1097\/ms9.0000000000002214","article-title":"A brief review of current treatment options for osteoarthritis including disease-modifying osteoarthritis drugs (Dmoads) and novel therapeutics","volume":"86","author":"Jiang","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2023.100404","article-title":"Efficacy of tumor necrosis factor inhibitors in hand osteoarthritis: A systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Estee","year":"2023","journal-title":"Osteoarthr Cartil Open"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glz239","article-title":"Nlrp3 inflammasome inhibition by Mcc950 in aged mice improves health via enhanced autophagy and Ppar\u03b1 activity","volume":"75","author":"Mar\u00edn-Aguilar","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-019-00151-6","article-title":"Blockade of the Nlrp3 inflammasome improves metabolic health and lifespan in obese mice","volume":"42","author":"Ca\u00f1adas-Lozano","year":"2020","journal-title":"Geroscience"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015036","article-title":"Impaired Nlrp3 inflammasome activation\/pyroptosis leads to robust inflammatory cell death via caspase-8\/Ripk3 during coronavirus infection","volume":"295","author":"Zheng","year":"2020","journal-title":"J Biol Chem"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-021-00948-8","article-title":"Erythropoietin abrogates post-ischemic activation of the Nlrp3, Nlrc4, and Aim2 inflammasomes in microglia\/macrophages in a Tak1-dependent manner","volume":"13","author":"Heinisch","year":"2022","journal-title":"Transl Stroke Res"},{"key":"B153","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12964-023-01466-w","article-title":"Cgas-Sting, inflammasomes and pyroptosis: An overview of crosstalk mechanism of activation and regulation","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B154","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13075-023-03075-x","article-title":"Sting mediates experimental osteoarthritis and mechanical allodynia in mouse","volume":"25","author":"Shin","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S392652","article-title":"The role of Aim2 inflammasome in knee osteoarthritis","volume":"15","author":"Yang","year":"2022","journal-title":"J Inflammation Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1081323","article-title":"The molecular mode of action and species specificity of Canakinumab, a human monoclonal antibody neutralizing Il-1\u03b2","volume":"7","author":"Rondeau","year":"2015","journal-title":"MAbs"},{"key":"B157","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.immuni.2020.06.007","article-title":"Caspase-1 engages full-length Gasdermin D through two distinct interfaces that mediate caspase recruitment and substrate cleavage","volume":"53","author":"Liu","year":"2020","journal-title":"Immunity"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of Canakinumab in the Cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-209031","article-title":"Canakinumab treatment for patients with active recurrent or chronic Tnf receptor-associated periodic syndrome (Traps): An open-label, phase II study","volume":"76","author":"Gattorno","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.835054","article-title":"Rs3806265 and Rs4612666 of the Nlrp3 gene are associated with the titer of glutamic acid decarboxylase antibody in type 1 diabetes","volume":"13","author":"Sun","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.690860","article-title":"Association of Nlrp3 Rs35829419 and Rs10754558 polymorphisms with risks of autoimmune diseases: A systematic review and meta-analysis","volume":"12","author":"Wu","year":"2021","journal-title":"Front Genet"},{"key":"B163","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1158\/1541-7786.Mcr-10-0565","article-title":"Differential roles for the interferon-inducible Ifi16 and Aim2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts","volume":"9","author":"Duan","year":"2011","journal-title":"Mol Cancer Res"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (Gdp): A comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1938807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:00:02Z","timestamp":1790258402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1938807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":164,"alternative-id":["10.3389\/fimmu.2026.1938807"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1938807","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1938807"}}